Evidence map›Paper›PMID 34604928›Full record

ArticleJournal of the Egyptian National Cancer Institute2021

Impact of different treatment plans on EQD

Osman Vefa Gul, Gokcen Inan, Hamit Basaran

Abstract read
In one paragraph

Article in Journal of the Egyptian National Cancer Institute, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Efficacy and Safety ofCancer reports (Hoboken, N.J.) · 2024
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Osman Vefa GulDepartment of Radiation Oncology, Faculty of Medicine, Selcuk University, Konya, Turkey. vefagul@selcuk.edu.tr.ORCID http://orcid.org/0000-0002-6773-3132
Gokcen InanDepartment of Radiation Oncology, Faculty of Medicine, Selcuk University, Konya, Turkey.
Hamit BasaranDepartment of Radiation Oncology, Faculty of Medicine, Selcuk University, Konya, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer is one of the leading causes of death worldwide. According to GLOBOCAN estimates, there were 341,831 deaths from cervical cancer in 185 countries in 2020. The aim of this study was to compare equieffective dose (EQD

methodsFifteen patients with stage IIB-IIIB cervical cancer were included in this retrospective study. Treatment with three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT) was planned for all patients in 28 fractions, with a total of 50.4 Gy to be delivered to the whole pelvic region. After EBRT, manual optimization (MO) or inverse optimization (IO) HDR-BRT plans were created in 4 fractions with a total of 28 Gy. The plans obtained were grouped as IMRT + IO, IMRT + MO, 3DCRT + IO, and 3DCRT + MO by calculating EQD

resultsThere was no significant difference between the treatment groups in terms of CTV

conclusionsConsidering all parameters such as CTV

Indexed as

BrachytherapyRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedUterine Cervical NeoplasmsFemaleHumansRetrospective StudiesBrachytherapyCervical cancerEQD2

Identifiers

PMID34604928
PMCPMC13317014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.